Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E43.25 EPS (ttm)2.02 Insider Own0.20% Shs Outstand1.79B Perf Week-1.39%
Market Cap156.44B Forward P/E21.80 EPS next Y4.01 Insider Trans-14.85% Shs Float1.76B Perf Month-4.80%
Income3.60B PEG3.90 EPS next Q0.71 Inst Own77.10% Short Float1.03% Perf Quarter3.75%
Sales31.90B P/S4.90 EPS this Y34.30% Inst Trans0.70% Short Ratio3.90 Perf Half Y3.00%
Book/sh17.96 P/B4.87 EPS next Y11.23% ROA4.30% Target Price100.14 Perf Year16.38%
Cash/sh2.42 P/C36.09 EPS next 5Y11.08% ROE9.30% 52W Range72.36 - 92.45 Perf YTD0.68%
Dividend1.44 P/FCF79.25 EPS past 5Y2.00% ROI6.10% 52W High-5.41% Beta1.10
Dividend %1.65% Quick Ratio1.10 Sales past 5Y9.20% Gross Margin58.60% 52W Low20.85% ATR1.40
Employees103000 Current Ratio1.50 Sales Q/Q5.50% Oper. Margin12.40% RSI (14)44.52 Volatility1.46% 1.44%
OptionableYes Debt/Eq0.60 EPS Q/Q61.80% Profit Margin9.10% Rel Volume1.17 Prev Close88.46
ShortableYes LT Debt/Eq0.55 EarningsJan 22 BMO Payout73.10% Avg Volume4.65M Price87.45
Recom1.90 SMA20-1.70% SMA50-0.23% SMA2004.05% Volume5,427,633 Change-1.14%
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Feb-21-20 06:16PM  Mairs and Power: Top 4th-Quarter Trades GuruFocus.com
04:36PM  Insulet Partners With Abbott and DexCom On Diabetes GuruFocus.com
11:30AM  Abbott (ABT) Down 2.5% Since Last Earnings Report: Can It Rebound? Zacks
10:57AM  Abbott Declares 385th Consecutive Quarterly Dividend PR Newswire
10:00AM  This Medical Giant Slipped Below A Buy Zone Should You Bet On It? Investor's Business Daily
Feb-20-20 08:00AM  New Real-World Data Show that Abbott's FreeStyle Libre System Delivers Positive Health Outcomes for People with Type 1 and Type 2 Diabetes PR Newswire
Feb-19-20 02:02PM  Abbott Laboratories: Why Adding More of This Health Care Giant Makes Sense GuruFocus.com
06:30AM  Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care PR Newswire
Feb-18-20 07:45AM  Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity PR Newswire
Feb-17-20 05:44AM  Should You Think About Buying Abbott Laboratories (NYSE:ABT) Now? Simply Wall St.
Feb-14-20 04:37PM  This Leading Diabetes Stock Just Launched Into A Profit-Taking Zone Investor's Business Daily
Feb-11-20 06:47AM  Novacyt biotech company says winning race for high-speed virus test Reuters
Feb-10-20 03:51PM  FOCUS-Countries rush to build diagnostic capacity as coronavirus spreads Reuters
Feb-06-20 05:36PM  J&J Brand Most Valuable Among Pharmaceutical Companies GuruFocus.com
04:47PM  Not Finding ETFs In Buy Areas? Here's One That Beats The S&P 500 Investor's Business Daily
05:00AM  Three Trends for 2020- Dividend Growth, Sustainable Impact and the Election MoneyShow
Feb-05-20 08:52AM  Medical Products Stock Feb 6 Earnings Roster: BDX, CAH & More Zacks
Feb-04-20 03:27PM  Time To Appreciate This Cheap Vanguard Dividend ETF Benzinga
Feb-03-20 09:00AM  Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke PR Newswire
Feb-01-20 07:54AM  India raises import taxes in move set to spook some foreign firms Reuters
Jan-30-20 04:33PM  Apples Success Reversing Patent Cases May Dim CalTechs Win Bloomberg
10:54AM  These 4 Biotech Stocks Are the Silver Lining on the Wuhan Coronavirus GuruFocus.com
Jan-29-20 05:57PM  Joel Greenblatt: Is There Still an Edge to Be Found in the Market? GuruFocus.com
07:09AM  Edited Transcript of ABT earnings conference call or presentation 22-Jan-20 2:30pm GMT Thomson Reuters StreetEvents
Jan-28-20 09:52AM  How Alameda again became a biotech hotspot American City Business Journals
05:21AM  Should You Care About Abbott Laboratoriess (NYSE:ABT) Investment Potential? Simply Wall St.
Jan-24-20 09:00AM  Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease PR Newswire
Jan-23-20 07:24AM  The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment Benzinga
Jan-22-20 03:12PM  ABT Options Traders Pour In as Stock Hits New High Schaeffer's Investment Research
02:48PM  This local regenerative medicine company is plotting its IPO American City Business Journals
02:28PM  Health stocks reverse coronavirus gains as one analyst says the market is overreacting Yahoo Finance
01:33PM  Abbott beats revenue projections as sales outperform previous year American City Business Journals
12:30PM  Abbott hits all-time high on quarterly revenue beat Reuters
10:42AM  Breaking Q4 Earnings News Zacks
10:32AM  Incoming Abbott CEO says not looking to do any deals Reuters
10:24AM  Chicago Econ Numbers & More Q4 Earnings: JNJ, ABT, FITB Zacks
10:07AM  Abbott (ABT) Q4 Earnings Match Estimates, Revenues Beat Mark Zacks
09:37AM  Health Giant Abbott Labs Beats Fourth-Quarter Sales Views And Rises In Buy Zone Investor's Business Daily
09:06AM  Dow Trades Higher as IBM Jumps, S&P 500 and Nasdaq Set Record Highs TheStreet.com
08:45AM  Abbott (ABT) Meets Q4 Earnings Estimates Zacks
08:03AM  Shares of Abbott Labs are up 1%; sales are up 7% MarketWatch
07:45AM  Abbott hits all-time high on quarterly revenue beat Reuters
04:35AM  Abbott Labs Hits Mark on Fourth-Quarter Earnings, Boosts Guidance TheStreet.com
02:32AM  Abbott Labs Earnings inline, Revenue Beats In Q4 Investing.com
Jan-21-20 01:42PM  Q4 Earnings Preview: Abbott Laboratories Benzinga
09:10AM  Abbott Laboratories Could Climb to the $107 Area Next TheStreet.com
Jan-20-20 02:04PM  The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings Benzinga
09:13AM  Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines? Zacks
09:08AM  As the stock market races to uncharted territory, irrationally bullish investors are getting nervous MarketWatch
Jan-17-20 07:34PM  How Alibaba and Tencent Brought Mobile Payments to Chinese New Year Barrons.com
08:27AM  Diabetes Management Gains FDA Attention: 3 Stocks in Focus Zacks
06:51AM  3 Big Stock Charts for Friday: IBM, Abbott Labs, and FuelCell Energy InvestorPlace
Jan-16-20 08:55AM  3 Medical Product Stocks Set to Beat This Earnings Season Zacks
Jan-15-20 12:30PM  Abbott (ABT) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Jan-14-20 11:00AM  7 Dividend ETFs That Offer Growth in 2020 Zacks
Jan-13-20 02:39PM  The Funded: Rush of healthcare fundings as big S.F. conference gets underway American City Business Journals
09:00AM  Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients PR Newswire
Jan-10-20 04:19PM  IBD Stock Of The Day Dexcom Is Breaking Out To A Record High Here's Why Investor's Business Daily
Jan-08-20 10:18AM  Abbott Laboratories CFO to retire in February MarketWatch
09:23AM  Abbott's Less-Invasive Surgery for Heart Pump Gets FDA Nod Zacks
05:02AM  A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT) Simply Wall St.
Jan-07-20 03:40PM  Abbott gets FDA approval for less-invasive heart pump implant procedure American City Business Journals
10:04AM  FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery PR Newswire
Jan-02-20 09:00AM  Abbott Hosts Conference Call for Fourth-Quarter Earnings PR Newswire
08:14AM  The Dow Rockets Higher as Beijing Moves to Speed Up Growth. China-Related Stocks Are Rising Barrons.com
Dec-30-19 02:43PM  Court orders Boston Scientific to complete $275M acquisition American City Business Journals
09:23AM  The Zacks Analyst Blog Highlights: Facebook, Alibaba, Mastercard, Abbott Laboratories and Philip Morris International Zacks
08:57AM  The Zacks Analyst Blog Highlights: AbbVie, Abbott Labs, Allergan, Johnson & Johnson and Merck Zacks
Dec-27-19 04:25PM  Abbott Laboratories (ABT) vs. Hedge Fund Favorites in 2019 Insider Monkey
04:15PM  3 Dividend-Paying Large Cap Pharma Stocks to Consider for 2020 Zacks
03:43PM  Top Stock Reports for Facebook, Alibaba & Mastercard Zacks
Dec-20-19 12:51PM  LifeScan Global Corporation -- Moody's revises LifeScan's outlook to negative, affirms B2 CFR Moody's
Dec-19-19 05:45AM  Does Abbott Laboratories (NYSE:ABT) Create Value For Shareholders? Simply Wall St.
Dec-18-19 05:50PM  Abbott (ABT) Dips More Than Broader Markets: What You Should Know Zacks
Dec-14-19 08:00AM  Animal-Care Provider Zoetis and 6 More Companies Are Raising Dividends Barrons.com
Dec-13-19 11:03AM  Urbem's 'Wonderful Business' Series: Bioventix GuruFocus.com
10:54AM  Abbott Labs raises quarterly dividend by 12.5% to 36 cents a share MarketWatch
10:39AM  Abbott Raises Quarterly Dividend 12.5%, Increasing Payouts for 48 Straight Years PR Newswire
Dec-11-19 07:09AM  Aung San Suu Kyi defends Myanmar against genocide claims in UN court Financial Times
Dec-09-19 05:50PM  Abbott (ABT) Dips More Than Broader Markets: What You Should Know Zacks
Dec-04-19 05:00AM  Money in Medicine: These drug and device companies paid the most to D.C. doctors in 2018 American City Business Journals
Dec-02-19 05:50PM  Abbott (ABT) Dips More Than Broader Markets: What You Should Know Zacks
Nov-30-19 05:44PM  Hedge Funds Have Never Been This Bullish On Abbott Laboratories (ABT) Insider Monkey
Nov-28-19 11:37AM  What To Know Before Buying Abbott Laboratories (NYSE:ABT) For Its Dividend Simply Wall St.
08:14AM  Digital Diabetes Management Gains Momentum: 3 Stocks in Focus Zacks
Nov-26-19 09:03AM  The Zacks Analyst Blog Highlights: Abbott, Philip Morris, Lowe's, Equinix and Kinder Morgan Zacks
Nov-25-19 02:49PM  Top Analyst Reports for Abbott, Philip Morris & Lowe's Zacks
Nov-24-19 08:03PM  Here is 16th Most Popular Stock Among 752 Hedge Funds Insider Monkey
Nov-19-19 12:07PM  Mairs and Power Sells UPS, Abbott Labs GuruFocus.com
Nov-16-19 03:54PM  UPDATE 1-Stents no better than drugs for many heart patients -U.S. study Reuters
02:00PM  Stents no better than drugs for many heart patients -U.S. study Reuters
Nov-15-19 09:30AM  Abbott (ABT) Up 2.1% Since Last Earnings Report: Can It Continue? Zacks
Nov-14-19 08:14AM  A Fresh Look at Abbott Labs Still Shows a Long-Term Uptrend in Place TheStreet.com
Nov-13-19 04:29PM  Medtech Giant Elects New CEO As 21-Year Veteran Steps Down Investor's Business Daily
11:23AM  Abbott CEO Miles White Steps Down Benzinga
09:57AM  Abbott Labs CEO White to step down after 21 years American City Business Journals
09:30AM  Abbott Labs Chooses an Insider to Be Its New CEO Barrons.com
08:23AM  UPDATE 2-Abbott CEO Miles White to step down next year Reuters
07:58AM  Abbott Laboratories CEO Miles White to step down after 2 decades in charge MarketWatch
07:55AM  Abbott CEO Miles White to step down next year Reuters
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moreland Mary KExecutive Vice PresidentFeb 19Sale88.971,01990,66052,985Feb 19 05:53 PM
DALE MICHAEL DSenior Vice PresidentFeb 19Sale88.9739635,23223,947Feb 19 05:53 PM
Wainer Andrea FExecutive Vice PresidentFeb 07Sale88.611,12099,24540,140Feb 11 06:10 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Option Exercise45.33509,85023,110,674624,231Jan 30 05:23 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Sale89.73509,85045,747,209114,381Jan 30 05:23 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Option Exercise38.4037,5001,440,00088,032Jan 29 05:06 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Sale89.5837,5003,359,41150,534Jan 29 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Option Exercise38.4016,000614,40068,562Oct 25 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Sale80.5421,0001,691,31547,562Oct 25 05:02 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Option Exercise47.0047,2262,219,62297,755Sep 04 05:20 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Sale85.1447,2264,020,68550,532Sep 04 05:20 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Option Exercise50.7223,0081,166,966104,228Aug 13 07:12 PM
Funck Robert ESenior Vice PresidentAug 09Option Exercise34.9440,0001,397,600178,991Aug 13 07:11 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Sale86.3923,0081,987,70581,220Aug 13 07:12 PM
YOOR BRIAN BExecutive Vice President & CFOAug 08Option Exercise38.0343,7631,664,357158,144Aug 09 05:05 PM
YOOR BRIAN BExecutive Vice President & CFOAug 08Sale85.7743,7633,753,706114,381Aug 09 05:05 PM
Blount Sally E.DirectorJul 31Sale87.652,500219,12126,266Aug 02 05:01 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentJul 24Option Exercise38.4065,0002,496,000117,562Jul 26 09:30 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentJul 24Sale88.0165,0005,720,32552,562Jul 26 09:30 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 26Option Exercise38.4071,0002,726,400167,148Jun 27 05:01 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 26Sale84.0071,0005,964,00796,148Jun 27 05:01 PM
Wainer Andrea FExecutive Vice PresidentJun 21Sale85.131,188101,13441,260Jun 24 05:59 PM
ALLEN HUBERT LExecutive Vice PresidentJun 20Option Exercise34.94165,0005,765,100311,010Jun 21 05:19 PM
CAPEK JOHN MExecutive Vice PresidentJun 20Option Exercise26.1946,9001,228,213355,435Jun 21 05:20 PM
CAPEK JOHN MExecutive Vice PresidentJun 20Sale85.0046,9003,986,500308,535Jun 21 05:20 PM
ALLEN HUBERT LExecutive Vice PresidentJun 20Sale85.00165,00014,025,000146,010Jun 21 05:19 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 13Sale82.003,331273,14296,148Jun 13 05:12 PM
LANE ANDREW HExecutive Vice PresidentJun 12Option Exercise48.9073,4243,590,434119,362Jun 14 05:03 PM
LANE ANDREW HExecutive Vice PresidentJun 12Sale81.4273,4245,978,19745,938Jun 14 05:03 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 11Sale82.007,269596,05899,479Jun 13 05:12 PM
Blaser Brian JExecutive Vice PresidentMay 23Option Exercise38.43450,06217,294,801580,807May 24 05:02 PM
Blaser Brian JExecutive Vice PresidentMay 23Sale75.52450,06233,988,727130,745May 24 05:02 PM
Watkin JaredSenior Vice PresidentMay 02Option Exercise46.18309,42914,290,631383,964May 06 05:04 PM
Watkin JaredSenior Vice PresidentMay 02Sale78.51309,42924,294,19974,535May 06 05:04 PM
Contreras JaimeSenior Vice PresidentApr 26Option Exercise38.4080,8603,105,024115,566Apr 29 05:35 PM
Contreras JaimeSenior Vice PresidentApr 25Option Exercise51.3082,7324,243,867117,438Apr 29 05:35 PM
Contreras JaimeSenior Vice PresidentApr 25Sale70.0082,7325,791,48734,706Apr 29 05:35 PM
Fussell Stephen RExecutive Vice PresidentApr 23Option Exercise47.0056,0002,632,000225,935Apr 24 05:10 PM
Fussell Stephen RExecutive Vice PresidentApr 23Sale76.0056,0004,256,000169,935Apr 24 05:10 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 22Buy73.402,000146,79852,562Apr 24 05:05 PM
Contreras JaimeSenior Vice PresidentApr 22Sale73.1291867,1242,227Apr 24 05:06 PM
MANNING JOSEPH JSenior Vice PresidentMar 20Sale79.585,613446,66550,529Mar 21 05:10 PM
WHITE MILES DChairman and CEOMar 18Option Exercise24.29589,70014,324,3233,763,865Mar 20 05:29 PM
WHITE MILES DChairman and CEOMar 18Sale78.5576,0695,974,9893,174,165Mar 20 05:33 PM
WHITE MILES DChairman and CEOMar 18Sale78.5281,5806,405,7813,326,190Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.5775,9565,967,8373,250,234Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.6274,2225,835,4013,613,904Mar 20 05:29 PM
WHITE MILES DChairman and CEOMar 18Sale78.5176,7196,023,1533,537,185Mar 20 05:30 PM
WHITE MILES DChairman and CEOMar 18Sale78.65128,31510,092,3573,408,870Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.6175,7395,953,9543,688,126Mar 20 05:29 PM
BIRD ROGERSenior Vice PresidentMar 13Sale79.069,188726,41659,807Mar 14 05:01 PM
Bracken Sharon JSenior Vice PresidentMar 06Sale77.835,500428,07444,919Mar 08 05:07 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale78.002,246175,188114,381Mar 04 05:35 PM
Watkin JaredSenior Vice PresidentMar 01Sale78.001,391108,49874,535Mar 04 05:33 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 01Sale78.001,664129,792106,748Mar 04 05:32 PM
MANNING JOSEPH JSenior Vice PresidentMar 01Sale78.001,22395,39456,142Mar 04 05:30 PM
Fussell Stephen RExecutive Vice PresidentMar 01Sale78.002,246175,188169,935Mar 04 05:26 PM
Funck Robert ESenior Vice PresidentMar 01Sale78.001,00278,156138,991Mar 04 05:24 PM
Contreras JaimeSenior Vice PresidentMar 01Sale78.2812,561983,286103,446Mar 04 05:23 PM
Blaser Brian JExecutive Vice PresidentMar 01Sale78.2316,1551,263,737130,745Mar 04 05:18 PM
Bracken Sharon JSenior Vice PresidentMar 01Sale78.001,22495,47250,419Mar 04 05:19 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 01Sale78.001,00278,15641,111Mar 04 05:21 PM
ALLEN HUBERT LExecutive Vice PresidentMar 01Sale78.002,246175,188146,010Mar 04 05:17 PM
BIRD ROGERSenior Vice PresidentMar 01Sale78.001,11386,81468,995Mar 04 05:18 PM